The effects of age, height velocity over the preceding year, glomerular filtration rate (GFR) and prednisolone dose on growth response have been assessed by single and multiple linear regression analysis in 23 prepubertal children [age, mean (SD), 8.2 (2.5) years] with chronic renal failure (CRF) and 16 prepubertal children [12.1 (2.3) years] with renal transplants treated for 1 year with recombinant human growth hormone (rhGH), 30 U/m2 per week. Height velocity [mean (SD), cm/year increased from 4.7 (1.3) to 9.7 (2.1) (P<0.0001) in the CRF group and 3.1 (1.6) to 7.3 (2.8) (P<0.0001) in the transplant group. In the CRF group, there was a correlation between age and height velocity, both in the pretreatment year (r=−0.755,P<0.0001) and during treatment (r=−0.421,P=0.045). There was no correlation between pretreatment height velocity or GFR and response to rhGH. In the transplanted children height velocity during the treatment year correlated with age (r=−0.647,P=0.007), prednisolone dose (r=−0.689,P=0.003), GFR (r=0.542,P=0.030) and pretreatment height velocity (r=0.655,P=0.006). Multiple regression analysis showed prednisolone dose and age to be the most important predictors of response.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Rees L, Rigden SPA, Ward G, Preece MA (1990) Treatment of short stature in renal disease with recombinant human growth hormone. Arch Dis Child 65: 856–861
Maxwell H, Nair DR, Dalton RN, Rigden SPA, Rees L (1995) Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure. Pediatr Nephrol 9: 458–464
Maxwell H, Nair DR, Dalton RN, Turner C, Saunders AJS, Rigden SPA, Rees L (1996) Effect of recombinant human growth hormone on renal function in children with renal transplants. J Pediatr 128: 177–183
Schwartz GJ, Haycock GB, Edelmann CM (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–263
Hindmarsh PC, Bridges NA, Brook CGD (1991) Wider implications for treatment with biosynthetic human growth hormone in children. Clin Endocrinol (OxF) 34: 417–427
Wühl E, Haffner D, Tonshoff B, Mehls O and the German Study Group for Growth Hormone Treatment in Chronic Renal Failure (1993) Predictors of growth response to rhGH in short children before and after renal transplantation. Kidney Int 44: S76-S82
Maxwell H, Rees L, on behalf of the British Association for Paediatric Nephrology (1996) Recombinant human growth hormone treatment in infants with chronic renal failure. Arch Dis Child 74: 40–44
Hokken-Koelega ACS, Stijnen T, De Muinck Keizer Schrama SMPF, Wit JM, Wolff ED, De Jong MCJW, Donkerwolcke RA, Abbad NCB, Bot A, Blum WF, Drop SLS (1991) Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338: 585–590
Wühl E, Haffner D, Nissel R, Schaefer F, Mehls O and the German Study Group for Growth Hormone Treatment in Chronic Renal Failure (1996) Short dialyzed children respond less to growth hormone than patients prior to dialysis. Pediatr Nephrol 10: 294–298
Rees L, Greene SA, Adlard P, Jones J, Haycock G, Rigden SPA, Preece M, Chantler C (1988) Growth and endocrine function after renal transplantation. Arch Dis Child 63: 1326–1332
About this article
Cite this article
Rees, L., Maxwell, H. Factors influencing the response to growth hormone in children with renal disease. Pediatr Nephrol 10, 337–339 (1996). https://doi.org/10.1007/BF00866775
- Recombinant human growth hormone
- Chronic renal failure